全文获取类型
收费全文 | 2427篇 |
免费 | 139篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 180篇 |
妇产科学 | 57篇 |
基础医学 | 361篇 |
口腔科学 | 108篇 |
临床医学 | 214篇 |
内科学 | 426篇 |
皮肤病学 | 122篇 |
神经病学 | 237篇 |
特种医学 | 64篇 |
外科学 | 233篇 |
综合类 | 14篇 |
一般理论 | 2篇 |
预防医学 | 198篇 |
眼科学 | 20篇 |
药学 | 186篇 |
中国医学 | 4篇 |
肿瘤学 | 140篇 |
出版年
2023年 | 13篇 |
2022年 | 26篇 |
2021年 | 49篇 |
2020年 | 38篇 |
2019年 | 54篇 |
2018年 | 66篇 |
2017年 | 50篇 |
2016年 | 67篇 |
2015年 | 55篇 |
2014年 | 99篇 |
2013年 | 132篇 |
2012年 | 165篇 |
2011年 | 174篇 |
2010年 | 95篇 |
2009年 | 85篇 |
2008年 | 165篇 |
2007年 | 185篇 |
2006年 | 165篇 |
2005年 | 141篇 |
2004年 | 156篇 |
2003年 | 122篇 |
2002年 | 140篇 |
2001年 | 20篇 |
2000年 | 19篇 |
1999年 | 16篇 |
1998年 | 20篇 |
1997年 | 33篇 |
1996年 | 19篇 |
1995年 | 33篇 |
1994年 | 20篇 |
1993年 | 19篇 |
1992年 | 19篇 |
1991年 | 13篇 |
1990年 | 9篇 |
1989年 | 8篇 |
1988年 | 4篇 |
1987年 | 3篇 |
1986年 | 8篇 |
1984年 | 14篇 |
1983年 | 10篇 |
1982年 | 9篇 |
1981年 | 4篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 6篇 |
1975年 | 2篇 |
1974年 | 4篇 |
1973年 | 3篇 |
1965年 | 2篇 |
排序方式: 共有2577条查询结果,搜索用时 0 毫秒
31.
32.
33.
34.
35.
36.
Kurt Seetoo Maria Paz Carlos David Blythe Leena Trivedi Robert Myers Tracey England Criscelia Agee Bill Arnold Carolyn Dobbs Mary McIntyre Enrique Ramirez Julie Morita Saadeh Ewaidah Wilete Ishow Teresa Chou Kenneth Soyemi Albert E. Barskey Amy Parker Fiebelkorn Paul Lucas Emily S. Abernathy Joseph P. Icenogle Gregory S. Wallace Susan E. Reef Yoran Grant 《MMWR. Morbidity and mortality weekly report》2013,62(12):226-229
37.
38.
Marko Lempinen Leena Halme Kirsti Numminen Johanna Arola Arno Nordin Heikki Mäkisalo 《Journal of hepato-biliary-pancreatic sciences》2005,12(5):409-414
Hepatobiliary cystadenomas and cystadenocarcinomas are rare tumors. Differentiating between these tumors and benign hepatic cysts may be difficult. Because of their rarity, diagnosis is often delayed and may result in inaccurate treatment, resulting in unnecessary morbidity and mortality. The purpose of this report is to draw attention to these entities and their complications. We report on two cases with spontaneous rupture of hepatobiliary cystadenoma and cystadenocarcinoma cysts, initially treated as simple hepatic cysts by aspiration, or by aspiration combined with sclerotherapy. The spontaneous rupture of the cysts appeared years after the initial treatment of the cysts, leading in one case to a prolonged stay in an intensive care unit. In both cases, a formal liver resection was carried out and microscopic investigations revealed a mucinous cystadenocarcinoma and cystadenoma. In conclusion, although hepatobiliary cystadenomas and cystadenocarcinomas are rare findings, they should not be forgotten in the diagnostic workshop when examining patients with hepatic cysts. If hepatobiliary cystadenomas and cystadenocarcinomas cannot be excluded following radiological imaging, surgery is recommended. 相似文献
39.
Jianjun Wang Sanna Ruotsalainen Leena Moilanen P?ivi Lepist? Markku Laakso Johanna Kuusisto 《European heart journal》2007,28(7):857-864
AIMS: The metabolic syndrome (MetS) is defined as a clustering of cardiovascular risk factors characterized by insulin resistance. We investigated the relationship of the MetS and its single components, defined by all six different criteria, with coronary heart disease (CHD), cardiovascular disease (CVD), and all-cause mortality in a prospective population-based study. METHODS AND RESULTS: The MetS was defined according to the World Health Organization (WHO), the European Group for the Study of Insulin Resistance (EGIR), the National Cholesterol Education Program (NCEP), the American College of Endocrinology (ACE), the International Diabetes Federation (IDF), and the American Heart Association (updated NCEP) criteria. We investgated the relationship of the MetS defined by aforementioned six criteria with CHD, CVD, and all-cause mortality with Cox regression analyses in a non-diabetic Finnish population of 1025 subjects, aged 65-74 years, during the 13-year follow-up. The MetS defined by all aforementioned criteria was associated with a statistically significant risk for CVD mortality when adjusted for all confounding variables (Hazards Ratios, HRs from 1.31 to 1.51). The MetS defined by the WHO, ACE, and IDF criteria was associated with an increased risk of CHD mortality (HRs from 1.42 to 1.58). There was no association between the MetS by any criteria and all-cause mortality. Of the single components of the MetS, the following predicted CVD mortality in multivariable models: impaired fasting glucose by the WHO, NCEP, and ACE criteria (HR 1.34) and by the IDF and updated NCEP criteria (HR 1.29); impaired glucose tolerance by the WHO and ACE criteria (HR 1.55); low HDL cholesterol by the EGIR criteria (HR 1.50) and by the NCEP, IDF, and updated NCEP criteria (HR 1.29); and microalbuminuria according to the WHO definition (HR 1.86). CONCLUSION: The MetS defined by all six current criteria predicts CVD mortality in elderly subjects. However, of the single components of the MetS, IFG, IGT, low HDL cholesterol, and microalbuminuria predicted CVD mortality with equal or higher HRs when compared with the different definitions of the MetS. Therefore, our study suggests that the MetS is a marker of CVD risk, but not above and beyond the risk associated with its individual components. 相似文献